PI3Kα-IN-25
PI3Kα-IN-25 (Compound Djh1) is a selective PI3Kα inhibitor. PI3Kα-IN-25 can be used in triple-negative breast cancer research[1].
Product Specifications
UNSPSC
12352005
Target
PI3K
Related Pathways
PI3K/Akt/mTOR
Field of Research
Cancer
Smiles
O=C1NC2=CC(Cl)=C(CCC3C(N=C(C4=CC=NC=C4)N=C3COC)=O)C=C2OC1
Molecular Formula
C21H19ClN4O4
Molecular Weight
426.85
References & Citations
[1]Halder D, et al. Exploring target selectivity in designing and identifying PI3Kα inhibitors for triple negative breast cancer with fragment-based and bioisosteric replacement approach. Sci Rep. 2025 Jan 13;15 (1) :1890.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PI3Kα
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400968-100 1x 100 µL
CD63 (LAMP3/968), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
